Xeloda

Active Ingredient(s): Capecitabine
FDA Approved: * April 30, 1998
Pharm Company: * HLR
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Xeloda Overview

Capecitabine, sold under the brand name Xeloda among others, is a chemotherapy medication used to treat breast cancer, gastric cancer and colorectal cancer.[1] For breast cancer it is often used together with docetaxel.[2] It is taken by mouth.[2] Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes.[2] Other severe side effects include blood clotting problems, allergic reactions, heart problems, a...

Read more Xeloda Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Capecitabine

Recent Xeloda Forums: RSS Feed

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Capecitabine
  • Tablet: 150mg, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Xeloda: (5 results)

Sorted by National Drug Code
  • 0004-1100 Xeloda 150 mg Oral Tablet by Genentech, Inc.
  • 0004-1101 Xeloda 500 mg Oral Tablet by Genentech, Inc.
  • 53808-0411 Xeloda 500 mg Oral Tablet by State of Florida Doh Central Pharmacy
  • 54868-4143 Xeloda 150 mg Oral Tablet by Physicians Total Care, Inc.
  • 54868-5260 Xeloda 500 mg Oral Tablet by Physicians Total Care, Inc.

Other drugs which contain Capecitabine or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA